0 CHECKOUT

Digestive Remedies in the United Arab Emirates

  • ID: 2477303
  • June 2015
  • Region: United Arab Emirates
  • 27 pages
  • Euromonitor International

In 2014 digestive remedies remained far from maturity in the United Arab Emirates. This can be attributed to low familiarity of the risks and treatment methods for digestive conditions amongst consumers. Whilst digestive health problems are prevalent in the country, misconceptions tend to prevent consumers from seeking treatment.

The Digestive Remedies in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

DIGESTIVE REMEDIES IN THE UNITED ARAB EMIRATES

June 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2009-2014
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2009-2014
Table 3 NBO Company Shares of Digestive Remedies: % Value 2010-2014
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2011-2014
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2014-2019
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2014-2019
Julphar Gulf Pharmaceuticals in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 1 Julphar Gulf Pharmaceutical: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Julphar Gulf Pharmaceutical: Competitive Position 2014
Executive Summary
Healthy Growth Continues in Consumer Health in the United Arab Emirates in 2014
Forecast Value Growth Is Threatened by GCC Price Harmonisation Initiative
the Strong Consumer Preference for Branded Products Is Difficult To Change
Chemists/pharmacies Continues To Lose Share
Strong Demand for Rx Products Poses A Threat To Demand for OTC Medicines
Key Trends and Developments
OTC Products Sees Healthy Growth in 2014, Driven by Growing Awareness of and Interest in Consumer Health
Raising Awareness of the Country's Rising Obesity Problem Is One of the Key Aims of the Government
GCC Price Harmonisation Impacts Development
Doctors Are Frequently Bypassed, As Patients Seek Advice From Pharmacists Or "dr Google"
50+ Age Group Becomes the Major Target of Marketing Campaigns for Vitamins and Dietary Supplements
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Distribution of Consumer Health by Format: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format and Category: % Value 2014
Table 15 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
Summary 3 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH